CATTANEO, GIULIA MARIA
CATTANEO, GIULIA MARIA
Dipartimento di Bioscienze
A novel chemically defined medium for the biotechnological and biomedical exploitation of the cell factory Leishmania tarentolae
2024 G.M. Cattaneo, I. Varotto-Boccazzi, R. Molteni, F. Ronchetti, P. Gabrieli, J.A. Mendoza-Roldan, D. Otranto, E. Montomoli, C. Bandi, S. Epis
Intracellular persistence of Leishmania tarentolae in primary canine macrophage cells
2023 V.N. Louzada-Flores, M.S. Latrofa, M.S. Lucente, B.P. Dambrós, J.A. Mendoza-Roldan, I. Varotto-Boccazzi, G.M. Cattaneo, G.F. Späth, A. Buonavoglia, D. Otranto
Rectal Administration of Leishmania Cells Elicits a Specific, Th1-Associated IgG2a Response in Mice: New Perspectives for Mucosal Vaccination against Leishmaniasis, after the Repurposing of a Study on an Anti-Viral Vaccine Candidate
2023 I. Varotto-Boccazzi, S. Epis, G.M. Cattaneo, N. Guerrini, A. Manenti, D. Rubolini, P. Gabrieli, D. Otranto, G. Zuccotti, E. Montomoli, C. Bandi
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein
2022 I. Varotto-Boccazzi, M. Garziano, G.M. Cattaneo, B. Bisaglia, P. Gabrieli, M. Biasin, A. Manenti, D. Rubolini, M. Clerici, E. Montomoli, G.V. Zuccotti, D. Trabattoni, S. Epis, C. Bandi
Efficacy of mucosal vaccination using a protozoan parasite as a vehicle for antigen delivery: IgG and neutralizing response after rectal administration of LeCoVax-2, a candidate vaccine against COVID-19
2022 S. Epis, I. Varotto-Boccazzi, A. Manenti, D. Rubolini, P. Gabrieli, G.M. Cattaneo, L. Gourlay, F. Dapporto, M. Monti, I. Razzano, M. Leonardi, M. Iannacone, C. Recordati, L. Bertola, P. Fiorina, L. Marvasi, E. Montomoli, G. Zuccotti, C. Bandi